相关实验视频

Updated: May 5, 2026

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Published on: July 26, 2011

阿尔茨海默氏症II型天体细胞在肝脏脑病变中的发展机制

Xiao Y Tong¹, Michael D Norenberg¹, Michael J Paidas²

¹Department of Pathology, University of Miami School of Medicine, Miami, FL, USA.

Neurochemistry international

|October 6, 2024

概括

质成熟因子 (GMF) 在慢性肝衰竭中驱动神经炎症和阿尔茨海默氏症II型星球细胞 (AT2A),导致认知和运动缺陷. 抑制GMF信号通路在老鼠模型中改善了这些效应.

科学领域:

神经科学是一个神经科学.
肝病学肝病学是一种肝病学.
分子生物学分子生物学

背景情况:

C型肝脑病变 (HE) 是慢性肝衰竭的严重神经并发症,其特征是认知和运动障碍.
阿尔茨海默氏症II型星体细胞 (AT2A) 是C型脑脊髓炎的一个关键的本病学标志,但它们的发育和缺陷中的作用尚不清楚.
以前的研究表明,肝衰竭模型中氧化/化应激 (ONS),JNK1/2和cMyc激活的增加.

研究的目的:

调查AT2A进展的机制及其在提奥乙胺 (TAA) 诱导的C型HE老鼠模型中的认知和运动缺陷中的作用.
探索星状细胞质成熟因子 (GMF) 和相关的炎症途径在C型HE病原发生过程中的参与.

主要方法:

利用乙胺 (TAA) 鼠标模型诱导慢性肝衰竭和C型HE.
分析了大脑皮质和星细胞培养,以检测GMF,炎症因子,GFAP和Lamin A/C的水平.
研究了对ONS,JNK1/2,cMyc和GMF的药理抑制对AT2A,炎症和行为缺陷的影响.

主要成果:

在接受TAA治疗的老鼠的大脑皮层中发现了高水平的GMF,炎症因子 (IL-1β,TNF-α,IL-6,MMP-3,COX2,CXCL1,PGE2) 和聚合的Lamin A/C.
在体外用氨治疗增加了星球细胞中的GMF和炎症因子.
在TAA大鼠中,抑制上游信号 (ONS,JNK1/2,cMyc) 和GMF显著降低了AT2A,炎症,并改善了认知和运动功能.

结论:

由升高的ONS,JNK1/2和cMyc驱动的天体细胞GMF增加,在慢性肝衰竭中促进神经炎症和AT2A形成.
转基因菌在与C型HE相关的认知和运动缺陷的发展中发挥着关键作用.
准GMF信号提供了一个潜在的治疗策略,用于管理慢性肝衰竭中神经系统并发症.

关键词:

氨气氨气氨气是一种认知和运动缺陷认知和运动缺陷格利亚成熟系数的成长因子肝脏脑病变肝脏脑病变是一种肝脏脑病变.炎症因素炎症因素

更多相关视频

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes

Published on: February 5, 2018

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...

Hepatic Encephalopathy

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...